Works matching AU RAJU, ADITYA

Results: 29

Economic Impact of Transformation to Acute Myeloid Leukemia Among Actively Managed Patients with Higher-Risk Myelodysplastic Syndromes in the United States.

Published in:

Advances in Therapy, 2023, v. 40, n. 4, p. 1655, doi. 10.1007/s12325-022-02370-4

By:

Kota, Vamsi;
Ogbonnaya, Augustina;
Farrelly, Eileen;
Schroader, Bridgette Kanz;
Raju, Aditya;
Kristo, Fjoralba;
Dalal, Mehul

Publication type:

Article

Impact of changes in reimbursement policies and institutional practice algorithm for utilization of erythropoietic-stimulating agents on treatment patterns and costs in anemic lymphoma patients.

Published in:

Supportive Care in Cancer, 2011, v. 19, n. 2, p. 251, doi. 10.1007/s00520-009-0811-3

By:

Subha Lal, Lincy;
Raju, Aditya;
Miller, Lesley-Ann;
Chen, Hua;
Arbuckle, Rebecca;
Sansgiry, Sujit S.

Publication type:

Article

Prevalence of pneumatisation patterns of Onodi cells among the North-East Indian population.

Published in:

Egyptian Journal of Otolaryngology, 2024, v. 40, n. 1, p. 1, doi. 10.1186/s43163-024-00673-7

By:

Shyamlal, Yadav Sagar;
Raju, K. Aditya Gopala;
Bhatnagar, Akshay;
Gianchand, Shikha;
Rai, Pankaj

Publication type:

Article

Outcomes related to postsurgical opioids.

Published in:

2015

By:

Minkowitz, Harold S.;
Gruschkus, Stephen K.;
Shah, Manan;
Raju, Aditya

Publication type:

Letter

Adverse drug events among patients receiving postsurgical opioids in a large health system: Risk factors and outcomes.

Published in:

American Journal of Health-System Pharmacy, 2014, v. 71, n. 18, p. 1556, doi. 10.2146/ajhp130031

By:

MINKOWITZ, HAROLD S.;
GRUSCHKUS, STEPHEN K.;
SHAH, MANAN;
RAJU, ADITYA

Publication type:

Article

Transfusion-free interval is associated with improved survival in patients with higher-risk myelodysplastic syndromes engaged in routine care.

Published in:

Leukemia & Lymphoma, 2019, v. 60, n. 1, p. 49, doi. 10.1080/10428194.2018.1464155

By:

Bell, Jill A.;
Galaznik, Aaron;
Blazer, Marlo;
Farrelly, Eileen;
Ogbonnaya, Augustina;
Raju, Aditya;
Eaddy, Michael;
Fram, Robert J.;
Faller, Douglas V.

Publication type:

Article

Impact of changes in reimbursement policies and institutional practice algorithm for utilization of erythropoietic-stimulating agents on treatment patterns and costs in anemic lymphoma patients.

Published in:

2010

By:

Lal LS;
Raju A;
Miller LA;
Chen H;
Arbuckle R;
Sansgiry SS;
Lal, Lincy Subha;
Raju, Aditya;
Miller, Lesley-Ann;
Chen, Hua;
Arbuckle, Rebecca;
Sansgiry, Sujit S

Publication type:

journal article

Healthcare Costs and Resource Utilization Associated with the Use of Empagliflozin Versus Other Antihyperglycemic Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Real-World Retrospective Cohort Analysis.

Published in:

Diabetes Therapy, 2022, v. 13, n. 1, p. 25, doi. 10.1007/s13300-021-01173-0

By:

Raju, Aditya;
Pimple, Pratik;
Stafkey-Mailey, Dana;
Farrelly, Eileen;
Shetty, Sharash

Publication type:

Article

Incremental burden of type 2 diabetes in patients experiencing cardiovascular hospitalizations.

Published in:

2018

By:

Coutinho, Anna D.;
Raju, Aditya D.;
Wang, Weijia;
Stafkey-Mailey, Dana;
Shetty, Sharash;
Sander, Stephen D.

Publication type:

journal article

Measuring the effect of therapy in rheumatoid arthritis clinical trials from the patient's perspective.

Published in:

Current Medical Research & Opinion, 2014, v. 30, n. 7, p. 1391, doi. 10.1185/03007995.2014.896328

By:

Rendas-Baum, Regina;
Bayliss, Martha;
Kosinski, Mark;
Raju, Aditya;
Zwillich, Samuel H.;
Wallenstein, Gene V.;
Koncz, Tamas

Publication type:

Article

Real-world impact of reminder packaging on antihypertensive treatment adherence and persistence.

Published in:

Patient Preference & Adherence, 2012, v. 6, p. 499, doi. 10.2147/PPA.S31417

By:

Dupclay, Leon;
Eaddy, Michael;
Jackson, James;
Raju, Aditya;
Shim, Andrew

Publication type:

Article

Real-world outcomes and factors impacting treatment choice in relapsed and/or refractory multiple myeloma (RRMM): a comparison of VRd, KRd, and IRd.

Published in:

Expert Review of Hematology, 2020, v. 13, n. 4, p. 421, doi. 10.1080/17474086.2020.1729734

By:

Chari, Ajai;
Richardson, Paul G.;
Romanus, Dorothy;
Dimopoulos, Meletios A.;
Sonneveld, Pieter;
Terpos, Evangelos;
Hajek, Roman;
Raju, Aditya;
Palumbo, Antonio;
Cain, Lauren E.;
Blazer, Marlo;
Huang, Hui;
Farrelly, Eileen;
Ailawadhi, Sikander

Publication type:

Article

Adoption of triplet therapy and clinical outcomes in routine practice among newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant in the USA.

Published in:

Expert Review of Hematology, 2019, v. 12, n. 1, p. 71, doi. 10.1080/17474086.2019.1555460

By:

Hari, Parameswaran;
Blazer, Marlo;
Raju, Aditya;
Farrelly, Eileen;
Labotka, Richard;
Skacel, Tomas;
Romanus, Dorothy

Publication type:

Article

Treatment Patterns and Outcomes in Patients with Varicose Veins.

Published in:

American Health & Drug Benefits, 2016, v. 9, n. 8, p. 455

By:

Mallick, Rajiv;
Raju, Aditya;
Campbell, Chelsey;
Carlton, Rashad;
Wright, David;
Boswell, Kimberly;
Eaddy, Michael

Publication type:

Article

Evaluating the Expected Costs and Budget Impact of Interventional Therapies for the Treatment of Chronic Venous Disease... [including commentary by Michael F. Murphy].

Published in:

American Health & Drug Benefits, 2015, v. 8, n. 7, p. 366

By:

Carlton, Rashad;
Mallick, Rajiv;
Campbell, Chelsey;
Raju, Aditya;
O'Donnell, Thomas;
Eaddy, Michael

Publication type:

Article

Cost and Quality Implications of Opioid-Based Postsurgical Pain Control Using Administrative Claims Data from a Large Health System: Opioid-Related Adverse Events and Their Impact on Clinical and Economic Outcomes.

Published in:

Pharmacotherapy, 2013, v. 33, n. 4, p. 383, doi. 10.1002/phar.1223

By:

Kessler, E. Richard;
Shah, Manan;
K. Gruschkus, Stephen;
Raju, Aditya

Publication type:

Article

MDS-357: Impact of Transformation to Acute Myeloid Leukemia (AML) on Overall Survival (OS) among Patients with Higher-Risk Myelodysplastic Syndromes (HR-MDS) in the United States of America (USA).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S348, doi. 10.1016/S2152-2650(21)01807-3

By:

Kota, Vamsi;
Ogbonnaya, Augustina;
Farrelly, Eileen;
Schroader, Bridgette;
Kristo, Fjoralba;
Raju, Aditya;
Dalal, Mehul

Publication type:

Article

Poster: MDS-357: Impact of Transformation to Acute Myeloid Leukemia (AML) on Overall Survival (OS) among Patients with Higher-Risk Myelodysplastic Syndromes (HR-MDS) in the United States of America (USA).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S227, doi. 10.1016/S2152-2650(21)01431-2

By:

Kota, Vamsi;
Ogbonnaya, Augustina;
Farrelly, Eileen;
Schroader, Bridgette;
Kristo, Fjoralba;
Raju, Aditya;
Dalal, Mehul

Publication type:

Article

Randomized Clinical Trial Representativeness and Outcomes in Real-World Patients: Comparison of 6 Hallmark Randomized Clinical Trials of Relapsed/Refractory Multiple Myeloma.

Published in:

2020

By:

Chari, Ajai;
Romanus, Dorothy;
Palumbo, Antonio;
Blazer, Marlo;
Farrelly, Eileen;
Raju, Aditya;
Huang, Hui;
Richardson, Paul

Publication type:

journal article

Treatment Patterns and Survival Outcomes in Patients With Follicular Lymphoma: A 2007 to 2015 Humedica Database Study.

Published in:

2019

By:

Morrison, Vicki A.;
Shou, Yaping;
Bell, Jill A.;
Hamilton, Laurie;
Ogbonnaya, Augustina;
Raju, Aditya;
Hennenfent, Kristin;
Eaddy, Michael;
Galaznik, Aaron

Publication type:

journal article

Randomized Clinical Trial (RCT) Representativeness and Outcomes Among Relapsed/Refractory Multiple Myeloma (RRMM) Patients Treated in the Real World (RW): Comparison of ASPIRE, TOURMALINE MM1, POLLUX, AND ELOQUENT-2 RCTS.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S249, doi. 10.1016/j.clml.2018.07.148

By:

Chari, Ajai;
Romanus, Dorothy;
Farrelly, Eileen;
Huang, Hui;
Blazer, Marlo;
Raju, Aditya;
Noga, Stephen;
Skacel, Tomas;
Richardson, Paul

Publication type:

Article

Prolonged Duration of Therapy Is Associated With Improved Survival in Patients Treated for Relapsed/Refractory Multiple Myeloma in Routine Clinical Care in the United States.

Published in:

2018

By:

Hari, Parameswaran;
Romanus, Dorothy;
Palumbo, Antonio;
Luptakova, Katarina;
Rifkin, Robert M.;
Tran, Linh Mai;
Raju, Aditya;
Farrelly, Eileen;
Noga, Stephen J.;
Blazer, Marlo;
Chari, Ajai

Publication type:

journal article

Association Between Treatment Regimen Type in Second-Line Therapy (2LT) and Duration of Therapy (DOT) & Time To Next Treatment (TTNT) in a United States (US) Relapsed/Refractory Multiple Myeloma (RRMM) Cohort.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e81, doi. 10.1016/j.clml.2017.03.147

By:

Romanus, Dorothy;
Raju, Aditya;
Yong, Candice;
Farrelly, Eileen;
Luptakova, Katarina;
Labotka, Richard;
Seal, Brian;
Noga, Stephen J.;
Blazer, Marlo;
Parameswaran, Hari

Publication type:

Article

Predictors of Treatment (tx) with Triplet First-Line Therapy (1LT) among Transplant-Ineligible Patients (pts) with Newly Diagnosed Multiple Myeloma (NDMM) in Routine Clinical Care.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e117, doi. 10.1016/j.clml.2017.03.212

By:

Romanus, Dorothy;
Raju, Aditya;
Seal, Brian;
Farrelly, Eileen;
Luptakova, Katarina;
Blazer, Marlo;
Parameswaran, Hari

Publication type:

Article

Treatment (tx) Patterns & Outcomes by Line of Therapy (LOT) in a Large United States (US) Cohort of Transplant-Ineligible Patients (pts) with Multiple Myeloma in the Era of Novel Agents.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e80, doi. 10.1016/j.clml.2017.03.146

By:

Romanus, Dorothy;
Raju, Aditya;
Seal, Brian;
Farrelly, Eileen;
Noga, Stephen J.;
Blazer, Marlo;
Parameswaran, Hari

Publication type:

Article

Newly Diagnosed Multiple Myeloma (NDMM): Effect of Age, Renal Insufficiency (RI), & Cardiovascular (CV) Disease (dz) on Overall Survival (OS) & Treatment (tx) Patterns Among Stem Cell Transplant (SCT)-Ineligible Patients (pts) in the United States (US)

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e82, doi. 10.1016/j.clml.2017.03.148

By:

Romanus, Dorothy;
Raju, Aditya;
Seal, Brian;
Farrelly, Eileen;
Skacel, Tomas;
Blazer, Marlo;
Parameswaran, Hari

Publication type:

Article

Triplet Therapy & Overall Survival (OS) in Routine Practice among Transplant-Ineligible Patients (pts) with Newly Diagnosed Multiple Myeloma (NDMM) in the United States (US).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e80, doi. 10.1016/j.clml.2017.03.145

By:

Romanus, Dorothy;
Raju, Aditya;
Seal, Brian;
Farrelly, Eileen;
Luptakova, Katarina;
Blazer, Marlo;
Parameswaran, Hari

Publication type:

Article

808-P: Economic Benefits of Initiating Empagliflozin vs. GLP-1 Receptor Agonists among Patients with Type 2 Diabetes.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-808-P

By:

PIMPLE, PRATIK;
RAJU, ADITYA;
FARRELLY, EILEEN;
SHETTY, SHARASH

Publication type:

Article

1152-P: Effect of Initiating Empagliflozin vs. Glucagon-Like Peptide-1 Receptor Agonists on Health-Care Costs among Patients with Type 2 Diabetes.

Published in:

Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1152-P

By:

PIMPLE, PRATIK;
RAJU, ADITYA;
STAFKEY-MAILEY, DANA;
SHETTY, SHARASH

Publication type:

Article